The $340 million, 30,000-square-foot center will produce cells for therapeutic applications.

Researchers use the technique to turn on Oct4 or Sox2 in mouse embryonic fibroblasts and convert them into pluripotent cells. 

The scientist was a member of a stem cell research team led by Nobel laureate Shinya Yamanaka. 

Michael Christman oversaw the organization’s well-known biobank and pioneered a personalized medicine initiative.

Combining gene editing and stem-cell induction improves efficiency of functional genetic analyses.

Simultaneous exposure to reprogramming and gene-editing plasmids efficiently produces edited pluripotent colonies.

Activating genes for reprogramming factors for a short time transforms large numbers of differentiated cells into multipotent forms that could be useful for cell-based therapies.

Researchers describe hundreds of induced pluripotent stem cell lines from healthy individuals. 

Using human induced pluripotent stem cells, scientists grew podocytes, cells that attach to the kidney's glomeruli and help filter blood.